by Benjamin Lund, Editor, Dentaltown Magazine
German-based VOCO America stays competitive with its wide array of improved-upon dental products while working on chemistry with its client dentists.
In the big scheme of things, if you take a look at the American
dental market, VOCO America, Inc., is merely a baby, but it didn’t
take too long for this company to start walking. With support
from its privately owned parent company VOCO GmbH Dental
Materials in Cuxhaven, Germany, VOCO America has made fast
and consistent gains since 2001 through products like Futurabond
DC, Profluorid Varnish and Grandio. Dentaltown Magazine recently interviewed Leif Ebert, president of VOCO America and
VOCO Canada, to learn more about the company, its German
heritage and its contribution to the future of dental products.
Leif, can you tell me a little bit about yourself,
and about your responsibilities as president of
VOCO America, Inc.?
Ebert: I am 38 years young, married and the proud dad of
our two-year old daughter. After I obtained my MBA, I joined
a consulting company in Hamburg, Germany. We helped start-up companies figure out their finances and we wrote business
plans that helped them receive money from state, federal or
European funds. In 1997, I joined VOCO’s marketing department
as a product manager and two years later I became director
of international marketing. At that time VOCO was already
active in more than 100 countries, but had not yet entered the
U.S. marketplace. When the company made plans to change
this, I was eager for them to give me the opportunity. There was
some initial hesitation in the beginning to give such a responsibility
to a young guy like me, but they did it and I am sure they
are happy today having made this move. I grew up next to an
American Army base and had a lot of American friends. As a
teenager I was familiar with the American culture and lifestyle,
which helped me to adapt our company strategies to the needs
of our U.S. customers.
As the President of VOCO America and VOCO Canada I
oversee all fields of our operation and supervise our 60 employees
in North America. Since my day-to-day routine consists of
lots of paperwork and working with lawyers, accountants, insurance
companies, etc., it is easy to lose touch with the customers.
To battle this, you will find me from time to time at trade shows
and visiting local dentists. I try to do what our sales consultants
do to understand the needs of our customers.
Tell me about the history of VOCO. What’s the
company’s business philosophy?
Ebert: Privately owned VOCO GmbH Dental Materials, a
worldwide active developer and manufacturer of advanced dental
materials, is in its 29th year of service to dentists and dental
technicians. What began in 1981 with a handful of products
and a very small staff, has developed into a worldwide active
operation of approximately 500 employees and more than 150
different dental materials; 60 of them are currently marketed in
the U.S. We limited the number of products for the U.S. market
in order to introduce only products that are better or different
from currently available products.
Today, we’re among the frontrunners in innovation and
we’ve made waves with the internationally acclaimed development
of highly biocompatible Ormocer-based restorative systems,
nano hybrid composites like Grandio and Grandio Flow
or a new generation of self-etch bonding systems (Futurabond).
We have the advantage that we are privately owned and can do
what is right for our customers and our business. We do not
have to act for short-time success in order to make shareholders
happy. Our strategy is very simple: listen to the customers and
give them products that meet or exceed their expectations.
Why and when did VOCO decide to branch out
into the American market?
Ebert: Many dentists have seen VOCO materials in different
parts of the world. They thought our products were unique and
realized the product penetration outside their own country. At
almost every trade show we were asked, “How can I get these
materials in the U.S.?” We entered Canada in 1997 and the
United States in 2001 to finally begin fulfilling these needs. We
waited quite a while to gain the financial strength that it takes to
start on a highly professional level in North America. My experience
is that many European companies underestimate the size and
the needs of the country and therefore cannot keep up with the
requirements. You need at least 20 representatives to start with to
provide half decent coverage and service to your customers. Today,
we have 47 consultants in the U.S. and eight in Canada and we
will continue expanding our network within the next years.
VOCO’s motto is “Creative in research.” Exactly
what does that mean and what key innovations has
VOCO’s research brought to the dental profession?
Ebert: a strong background in pharmaceuticals, Manfred Plaumann set
out to develop VOCO into a prime manufacturer of modern dental
materials. At the same time, the company was re-organized to
provide quality control and assurance according to the strict guidelines
of the German Pharmaceutical Act, which exceeds the
demands of the manufacturing of medical device guidelines by far.
Thus, focus was put on research and own development from the
very start. Other than most other major companies VOCO is
proud to develop and manufacture all of its chemistry-based products
on its own. “Creative in research” means that VOCO is committed
to follow the latest trends in dentistry by utilizing the lasted
available technology to provide superior
products that meets and exceeds the expectations
of our customers.
Can you tell me about what
goes into research and development
of a product at VOCO?
Ebert: It all starts with a product
idea that we often receive from our customers.
This idea will be taken from our
chemists to a clinician panel to get more input of what features
practitioners would expect from the new product. After our
chemists have finished the development of a product, it undergoes
toxicological tests at a partner university to ensure that the
product is harmless for its indicated use. Afterwards we send it
to universities around the world for biomaterial testing to confirm
our internal tests. Before the product goes to market we will
send the product back to our clinician panel for testing. Our
panel includes more than 100 dentists from around the world,
including leading universities. Only if their feedback is positive
will it go to market. A lot of times they give us change requests
that give our products the edge over other products.
You’re now calling yourselves “The Dentalists.”
What is a Dentalist?
Ebert: Our new slogan, “The Dentalists” expresses VOCO’s
exclusive specialization in dentistry. As dental material specialists,
we only concentrate on this field of activity and maintain
close cooperation with dentists and more than 150 universities
and research establishments across the globe.
The slogan “The Dentalists” is a commitment to all of our
employees. Intensive product training of our dental consultants
is key and an ongoing process. Our representatives act like consultants
to the clinicians rather than sales people. We are providing
solutions to clinical problems. Our consultants understand
the needs of clinicians and dentistry in whole. We do not have a
problem recommending another company’s product if it helps
to solve a clinical problem.
How are new technologies impacting the way
you develop and produce your products?
Ebert: At VOCO we are proud to use
state-of-the-art technology. There are a lot
of developments that make it easier to
manufacture products or give us new
opportunities to increase product quality.
Most of our manufacturing is totally automated,
which allows us to manufacture on
demand. That means we can start manufacturing the same day
that we receive an order from our distribution partner. This
ensures that our customers receive the freshest product possible.
On the other hand, new developments like the nano technology
allowed us to achieve a product quality that had never been possible
before. The first nano hybrid, Grandio, was developed
based on this technology. It allowed us to increase the filler
degree from 77 percent to 87 percent, which gave the composite
a much higher wear resistance and reduced the shrinkage by
up to 50 percent. Grandio was the first material of its kind and
we are proud that it has been copied by other manufacturers.
For VOCO, it is important to stay on top of new developments
at all times in order to keep our competitive advantage.
How would one of your customers describe VOCO?
Ebert: One time a dentist told me, “VOCO has Mercedes
products at Volkswagen prices.” I like this statement a lot. You
might be able to find more affordable products, but you will
have a hard time finding better products.
Is everything developed and manufactured in
Cuxhaven, Germany?
Ebert: Yes, we develop and manufacture 100 percent of our
chemistry-based products on our own in Cuxhaven, Germany.
We actually manufacture other brands for other companies and
dental distributors. The only thing we’ve outsourced is the manufacture
of our electric devices, like our curing lights. Other companies
are manufacturing them exclusively to our specifications.
How are your products distributed?
Ebert: Worldwide, we distribute only through our partner network of dental
distributors. In the U.S. it is through Patterson Dental and in Canada it is
Henry Schein, Sinclair and K-Dental as well as some smaller distributors. We
carefully pick our partners to make sure that they are committed to product
knowledge as well as distribution know-how. We have to make
sure that our customers receive the product in 24-to-48 hours.
In your opinion, what is the most important product
VOCO produces?
Ebert: This is difficult to answer, because we believe in all of our
products. Probably the most innovative products, next to Grandio,
are Grandio Flow and Futurabond DC. Grandio Flow sets a new
standard for flowable composites. It has a higher filler degree (80
percent) than most universal composites and performs more like a
universal composite than a flowable. Just recently Dr. John Burgess
of the University of Alabama, found in a two-year clinical trial that
Grandio Flow shows, in Class II restorations, no significant differences
in performance compared to a universal composite. This is a
breakthrough and goes against a common opinion that flowable
material is weaker than universals. The second innovation is
Futurabond DC, a dual-cured self-etch adhesive. The advantage for
the clinician is its versatility. Unlike other self-etch adhesives it can
be used also with dual- or self-cured resin cements and core build
up composites. This allows the clinicians to reduce the amount of
different adhesives for different procedures to just one, which makes
the training of staff members easier and reduces inventory.
How do you see dentistry changing in the future?
Ebert: The biggest change is probably in technology.
CAD/CAM and Digital X-rays are just the start. Digital impression
and CBCT technologies are just a few more innovations that
will make some headway in the future.
While it is important to stay on top of
technology it is also important to stay on
top of the innovations of chemistry-based
materials. Composites, bonding agents
and resin cements are changing as well and
getting better and better. The performance
of a 10-year-old composite and a modern
composite is not comparable. I know that
there are a lot of clinicians out there who
subscribe to the “if it ain’t broke, don’t fix it” philosophy. But isn’t
there a reason we buy new cars after a while? Why not stay also on
top with our day-to-day chemistry-based products?
On the other hand it is also important to fulfill the needs of our
customer on the packaging and application design. For example we
just designed a new syringe (NDT) for flowable composites and
sealants that solves the problem of runny and dripping material. For
our dual-cured self-etch adhesive Futurabond DC we developed a
single-dose delivery system that keeps the two components separate.
All the clinician has to do is squeeze it before the application in
order to mix the materials. This easy-to-use system overcomes the
problem of solvent evaporation of bottles and gives the clinician the
freshest possible chemistry for every patient every time.
What’s the five-year plan for VOCO?
Ebert: We have been very successful worldwide with our
philosophy of doing business. We will continue to develop state-of-the-art products
that fit the needs of our customers. The bigger change that you will see in North
America is that our presence will increase. Even in these slow economic times
we’ve
increased our number of dental consultants to improve our service
to the customer. We understand that clinicians want to see
and try a material before they commit to it. It is very critical that
we make sure that we continue to assist the customers after the
sale with any questions and requests they have.
Can you give us a little sneak peek into any new
developments or products VOCO is working
on
right now?
Ebert: VOCO’s strong focus on research has earned the
company the status of project leader of several German government
co-sponsored research projects, the latest being, biocompatible
materials for restoration and prosthodontics based on
monomer-free nano-composites. You will see the first products
out of these research projects within a few years.
In the next month we have two new innovative products. Amaris
Gingiva is a gingiva-colored composite system that can functionally
and aesthetically restore the gum line and is in many cases a good
alternative to expensive and time-consuming gum surgery.
The second product is Profluorid L, a five percent sodium
fluoride liquid varnish with calcium fluoride. This product was
especially developed to be used before, during and after bleaching
procedures without interfering with
the whitening procedure.
For more information on VOCO
America, Inc., please visit www.vocoamerica.com. |